This is an investigational study. Both fosaprepitant and rolapitant are FDA approved and commercially available for the prevention of nausea and vomiting that may be caused by chemotherapy. It is considered investigational to compare these 2 standard treatments to one another to learn if one is more effective than the other. The study doctor can explain how the study drugs are designed to work.